For patient information regarding , click [[{{{genericName}}} (patient information)|here]].
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====
Disclaimer
* Dosing Information
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
:* Dosage
Black Box Warning
=====Condition2=====
ConditionName:
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
See full prescribing information for complete boxed warning.
<!--Pediatric Indications and Dosage-->
ConditionName:
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Condition1=====
Content
* Dosing Information
Overview
:* Dosage
Sandbox drug2 is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
=====Condition2=====
Adult Indications and Dosage
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
FDA-Labeled Indications and Dosage (Adult)Condition1
<!--Off-Label Use and Dosage (Pediatric)-->
Dosing Information
Dosage
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport======Condition1=====
Condition2
* Developed by:
Dosing Information
Dosage
* Class of Recommendation:
Condition3
* Strength of Evidence:
Dosing Information
Dosage
* Dosing Information
Condition4
:* Dosage
Dosing Information
Dosage
=====Condition2=====
Off-Label Use and Dosage (Adult)Guideline-Supported UseCondition1
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
Developed by:
Class of Recommendation:
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport======Condition1=====
Strength of Evidence:
* Dosing Information
Dosing Information
:* Dosage
Dosage
=====Condition2=====
Condition2
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in adult patients.
<!--Contraindications-->
|contraindications=* Condition1
Non–Guideline-Supported Use
<!--Warnings-->
|warnings=* Description
Condition1
====Precautions====
Dosing Information
Dosage
* Description
Condition2
<!--Adverse Reactions-->
There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in adult patients.
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
Pediatric Indications and Dosage
=====Body as a Whole=====
FDA-Labeled Indications and Dosage (Pediatric)Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Sandbox drug2 in pediatric patients.
=====Cardiovascular=====
Off-Label Use and Dosage (Pediatric)
Guideline-Supported UseCondition1
Developed by:
Class of Recommendation:
Strength of Evidence:
=====Digestive=====
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in pediatric patients.
=====Endocrine=====
Non–Guideline-Supported Use
Condition1
Dosing Information
Dosage
Condition2
=====Hematologic and Lymphatic=====
There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in pediatric patients.
Contraindications
Condition1
Warnings
=====Metabolic and Nutritional=====
ConditionName:
See full prescribing information for complete boxed warning.
ConditionName:
Content
=====Musculoskeletal=====
Description
Precautions
Description
Adverse ReactionsClinical Trials Experience
There is limited information regarding Clinical Trial Experience of Sandbox drug2 in the drug label.
=====Neurologic=====
Body as a Whole
CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousPostmarketing Experience
There is limited information regarding Postmarketing Experience of Sandbox drug2 in the drug label.
Body as a Whole
=====Respiratory=====
CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousDrug Interactions
Drug
Description
Use in Specific PopulationsPregnancy
Pregnancy Category (FDA):
=====Skin and Hypersensitivy Reactions=====
Pregnancy Category
Pregnancy Category (AUS):
Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox drug2 in women who are pregnant.
=====Special Senses=====
Labor and Delivery
There is no FDA guidance on use of Sandbox drug2 during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Sandbox drug2 with respect to nursing mothers.
=====Urogenital=====
Pediatric Use
There is no FDA guidance on the use of Sandbox drug2 with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Sandbox drug2 with respect to geriatric patients.
=====Miscellaneous=====
Gender
There is no FDA guidance on the use of Sandbox drug2 with respect to specific gender populations.
Race
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
There is no FDA guidance on the use of Sandbox drug2 with respect to specific racial populations.
=====Body as a Whole=====
Renal Impairment
There is no FDA guidance on the use of Sandbox drug2 in patients with renal impairment.
Hepatic Impairment
=====Cardiovascular=====
There is no FDA guidance on the use of Sandbox drug2 in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Sandbox drug2 in women of reproductive potentials and males.
=====Digestive=====
Immunocompromised Patients
There is no FDA guidance one the use of Sandbox drug2 in patients who are immunocompromised.
Administration and Monitoring
=====Endocrine=====
Administration
Oral
Intravenous
Monitoring
=====Hematologic and Lymphatic=====
There is limited information regarding Monitoring of Sandbox drug2 in the drug label.
Description
IV Compatibility
=====Metabolic and Nutritional=====
There is limited information regarding IV Compatibility of Sandbox drug2 in the drug label.
Overdosage
Acute OverdoseSigns and Symptoms
=====Musculoskeletal=====
Description
Management
Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Sandbox drug2 in the drug label.
=====Neurologic=====
Pharmacology
Mechanism of Action
Structure
=====Respiratory=====
File:Sandbox drug201.png
This image is provided by the National Library of Medicine.
Pharmacodynamics
=====Skin and Hypersensitivy Reactions=====
There is limited information regarding Pharmacodynamics of Sandbox drug2 in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Sandbox drug2 in the drug label.
=====Special Senses=====
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Sandbox drug2 in the drug label.
Clinical Studies
=====Urogenital=====
There is limited information regarding Clinical Studies of Sandbox drug2 in the drug label.
How Supplied
Images
=====Miscellaneous=====
Drug Images
Drug Name:
Ingredient(s):
Imprint:
Dosage: {{{dosageValue}}} {{{dosageUnit}}}
Color(s):
Shape:
Size (mm):
Score:
NDC:
Drug Label Author:
<!--Drug Interactions-->
|drugInteractions=* Drug
:* Description
This pill image is provided by the National Library of Medicine's PillBox.
<!--Use in Specific Populations-->
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
Package and Label Display Panel
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
File:Sandbox drug211.png
<!--Administration and Monitoring-->
|administration=* Oral
This image of the FDA label is provided by the National Library of Medicine.
* Intravenous
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
Patient Counseling Information
* Description
There is limited information regarding Patient Counseling Information of Sandbox drug2 in the drug label.
<!--IV Compatibility-->
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
Precautions with Alcohol
<!--Overdosage-->
|overdose====Acute Overdose===
Alcohol-Sandbox drug2 interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
====Signs and Symptoms====
Brand Names
* Description
®[1]
Look-Alike Drug Names
====Management====
A® — B®[2]
Drug Shortage StatusPrice
* Description
References
===Chronic Overdose===
The contents of this FDA label are provided by the National Library of Medicine.
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
Jump up↑ You must specify title = and url = when using {{cite web}}..
<!--Pharmacology-->
<!--Drug box 2-->
|drugBox=<!--Mechanism of Action-->
|mechAction=*
<!--Structure-->
|structure=*
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
<!--Pharmacodynamics-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
<!--Pharmacokinetics-->
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
<!--Nonclinical Toxicology-->
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
<!--Clinical Studies-->
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
<!--How Supplied-->
|howSupplied=*
|packLabel=<!--Patient Counseling Information-->
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
<!--Precautions with Alcohol-->
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
<!--Brand Names-->
|brandNames=* ®<ref>{{Cite web | title = | url = }}</ref>
<!--Look-Alike Drug Names-->
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web | last = | first = | title = http://www.ismp.org | url = http://www.ismp.org | publisher = | date = }}</ref>
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
Content
Overview
Nimesulide is a {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Condition1
Dosing Information
Dosage
Condition2
Dosing Information
Dosage
Condition3
Dosing Information
Dosage
Condition4
Dosing Information
Dosage
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition1
Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Nimesulide in adult patients.
Non–Guideline-Supported Use
Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nimesulide in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Nimesulide in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Nimesulide in pediatric patients.
Non–Guideline-Supported Use
Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nimesulide in pediatric patients.
Contraindications
Condition1
Warnings
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
Content
Description
Precautions
Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Nimesulide in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Nimesulide in the drug label.